CN106519030B - 补体因子h抑制剂及与之相关的用途 - Google Patents
补体因子h抑制剂及与之相关的用途 Download PDFInfo
- Publication number
- CN106519030B CN106519030B CN201611201316.2A CN201611201316A CN106519030B CN 106519030 B CN106519030 B CN 106519030B CN 201611201316 A CN201611201316 A CN 201611201316A CN 106519030 B CN106519030 B CN 106519030B
- Authority
- CN
- China
- Prior art keywords
- cfh
- cancer
- inhibitor
- carcinoma
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4716—Complement proteins, e.g. anaphylatoxin, C3a, C5a
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611201316.2A CN106519030B (zh) | 2016-12-22 | 2016-12-22 | 补体因子h抑制剂及与之相关的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611201316.2A CN106519030B (zh) | 2016-12-22 | 2016-12-22 | 补体因子h抑制剂及与之相关的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106519030A CN106519030A (zh) | 2017-03-22 |
CN106519030B true CN106519030B (zh) | 2020-01-07 |
Family
ID=58337351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611201316.2A Active CN106519030B (zh) | 2016-12-22 | 2016-12-22 | 补体因子h抑制剂及与之相关的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106519030B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107118273B (zh) * | 2017-05-15 | 2020-02-18 | 广州泰诺迪生物科技有限公司 | 一种全人源抗补体因子h的抗体 |
US20220053741A1 (en) * | 2018-09-13 | 2022-02-24 | Regeneron Pharmaceuticals, Inc. | Complement Factor H Gene Knockout Rat as a Model of C3 Glomerulopathy |
CN110327457A (zh) * | 2019-08-09 | 2019-10-15 | 山东省千佛山医院 | Cfh在制备抗肺腺癌药物中的应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102649975A (zh) * | 2011-02-23 | 2012-08-29 | 张康 | 补体因子h基因型、载脂蛋白上氧化磷酸胆碱和血浆补体因子h定量测定试剂盒及测定方法 |
WO2014197885A2 (en) * | 2013-06-07 | 2014-12-11 | Duke University | Inhibitors of complement factor h |
CN104995516A (zh) * | 2013-02-26 | 2015-10-21 | 霍夫曼-拉罗奇有限公司 | 用于补体因子h相关蛋白质1检测的试剂、试剂盒和方法 |
-
2016
- 2016-12-22 CN CN201611201316.2A patent/CN106519030B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102649975A (zh) * | 2011-02-23 | 2012-08-29 | 张康 | 补体因子h基因型、载脂蛋白上氧化磷酸胆碱和血浆补体因子h定量测定试剂盒及测定方法 |
CN104995516A (zh) * | 2013-02-26 | 2015-10-21 | 霍夫曼-拉罗奇有限公司 | 用于补体因子h相关蛋白质1检测的试剂、试剂盒和方法 |
WO2014197885A2 (en) * | 2013-06-07 | 2014-12-11 | Duke University | Inhibitors of complement factor h |
Also Published As
Publication number | Publication date |
---|---|
CN106519030A (zh) | 2017-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102610592B1 (ko) | 당화 pd-l1에 특이적인 항체 및 그의 사용 방법 | |
JP5918540B2 (ja) | 抗dll3抗体 | |
JP6980075B2 (ja) | がん細胞特異的な抗体、抗がん剤、及びがんの検査方法 | |
WO2021069508A1 (en) | Antibodies having specificity for nectin-4 and uses thereof | |
JP2016538318A (ja) | 新規sez6モジュレーターおよび使用方法 | |
TW200823293A (en) | Novel anti-Notch3 antibodies and their use in the detection and diagnosis of disease | |
TWI756621B (zh) | 新型雙特異性抗體分子以及同時結合pd-l1和lag-3的雙特異性抗體 | |
WO2011105573A1 (ja) | 抗icam3抗体およびその用途 | |
US20230235078A1 (en) | Novel ddr1 antibodies and uses thereof | |
CN106519030B (zh) | 补体因子h抑制剂及与之相关的用途 | |
KR20180042423A (ko) | Cd37 의 검출을 위한 항체 및 검정 | |
JP6958817B2 (ja) | 抗tmem−180抗体、抗がん剤、及びがんの検査方法 | |
WO2022166876A1 (zh) | 特异性识别磷脂酰肌醇蛋白聚糖3的单克隆抗体及其应用 | |
JP5746018B2 (ja) | 抗tmprss11e抗体を用いた癌の診断と治療 | |
TW202204416A (zh) | 抗Claudin18.2抗體以及其用途 | |
WO2018222506A1 (en) | Modulation of immunoglobulin-a-positive cells | |
JP5857334B2 (ja) | 上皮性卵巣癌マーカー検出用抗体及び上皮性卵巣癌判定方法 | |
CN111303289B (zh) | 抗人Tn型糖基化MUC1抗体及其用途 | |
CN115298216A (zh) | 抗体或其抗原结合片段、其制备方法及医药用途 | |
JPWO2016171107A1 (ja) | Fgfr2の検出 | |
JP5849254B2 (ja) | 上皮性卵巣癌マーカー検出用抗体及び上皮性卵巣癌判定方法 | |
US20240117042A1 (en) | Immunohistochemistry methods and kir3dl2-specific reagents | |
WO2013172379A1 (ja) | 新規抗体及びその用途 | |
CN114901688A (zh) | 针对念珠菌的抗体及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 510300 unit 207, second floor, office area, No. 1, helix 4th Road, International Biological Island, Guangzhou, Guangdong Patentee after: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Patentee after: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee after: Jinan University Address before: 510300 unit 207, second floor, office area, No. 1, helix 4th Road, International Biological Island, Guangzhou, Guangdong Patentee before: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Patentee before: ZHUHAI TRINOMAB BIOTECHNOLOGY Co.,Ltd. Patentee before: Jinan University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230818 Address after: 519090 room 110, first floor, plant 6, No. 6366, Zhuhai Avenue, Jinwan District, Zhuhai City, Guangdong Province Patentee after: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee after: Jinan University Address before: 510300 unit 207, second floor, office area, No. 1, helix 4th Road, International Biological Island, Guangzhou, Guangdong Patentee before: GUANGZHOU TAINUODI BIOTECHNOLOGY Co.,Ltd. Patentee before: Zhuhai Tainuo Maibo Pharmaceutical Co.,Ltd. Patentee before: Jinan University |